Each month biotechnology, pharmaceutical and academic partners, large and small, working on treatments and a cure for myotonic dystrophy will sit down with our community to share their progress and answer your questions.
Learn more about PepGen at [ Ссылка ]
Speakers include:
+ Alayna Tress, MPH, Associate Director of Patient Advocacy
+ Michelle Mellion, MD, Senior Vice President & Head of Clinical Development
+ Jaya Goyal, PhD, Executive Vice President of Research and Preclinical Development
+ Holly Hand, Clinical Operations Consultant
+ Jane Larkindale, DPhil, Vice President of Clinical Science
0:00:00 - Welcome & Introduction
0:08:31 - Agenda
0:10:00 - About PepGen
0:16:54 - Summary of Functions Contributing to Drug Development & Patient Advocacy
0:24:58 - Preclinical Research & Development
0:27:36 - Clinical Operations
0:30:59 - Clinical Development
0:45:41 - Thank You & Contact for Additional Questions
0:46:20 - Q&A
